Vivimusta
Bendamustine hydrochloride · Azurity Pharmaceuticals, Inc.
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Vivimusta ingredients
| Active ingredient | Strength |
|---|---|
| Bendamustine Hydrochloride | 25 mg/mL |
What Vivimusta is used for
Vivimusta is a cancer medicine (alkylating drug). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Vivimusta
- Generic name
- Bendamustine hydrochloride
- Made by
- Azurity Pharmaceuticals, Inc.
- Forms
- Injection
- Given
- Intravenous
- Drug class
- Alkylating Drug
- FDA approval
- New drug application (NDA) NDA212209
- On the US market since
- 2022
Official information
- Vivimusta prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Bendamustine hydrochloride)
In India
- Bendamustine hydrochloride: 23 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Vivimusta?
Vivimusta (Bendamustine hydrochloride) is a cancer medicine made by Azurity Pharmaceuticals, Inc., approved by the US FDA.
What are the ingredients of Vivimusta?
Vivimusta contains Bendamustine Hydrochloride (25 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA